Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | GALR3 | O60755 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31546388 | 1.00 | HTT (0.60) | HTTKMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL31546349 | 0.92 | ALDH1A1 (0.54) | HTTKMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL30584903 | 0.92 | ALDH1A1 (0.56) | HTTKMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL25438262 | 0.89 | LMNA (0.62) | HTTKMT2AMEN1MAPTALDH1A1 | |
| SCHEMBL30584837 | 0.89 | LMNA (0.62) | HTTKMT2AMEN1MAPTALDH1A1 | |
| SCHEMBL31546425 | 0.84 | LMNA (0.63) | KMT2AMEN1MAPTSMN1; SMN2LMNA | |
| SCHEMBL30584862 | 0.83 | TSHR (0.59) | KMT2AMEN1MAPTALDH1A1TSHR | |
| SCHEMBL25432654 | 0.81 | KMT2A (0.54) | KMT2AMEN1L3MBTL1MAPTALDH1A1 | |
| SCHEMBL30584943 | 0.81 | KMT2A (0.54) | KMT2AMEN1L3MBTL1MAPTALDH1A1 | |
| SCHEMBL30584890 | 0.78 | LMNA (0.65) | KMT2AMEN1MAPTSMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4463452-A2 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | Anima Biotech Inc. (US) | 2024-11-20 | — | — | EP | disclosed |
| WO-2023177700-A2 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2023-09-21 | — | — | WO | disclosed |